Assessing Entegris (ENTG) Valuation After Recent Share Price Weakness And Stronger Long Term Returns

Entegris (ENTG) has been drawing attention after a recent stretch of mixed share performance, with a decline over the past month and a gain over the past 3 months prompting investors to reassess the semiconductor materials specialist.

See our latest analysis for Entegris.

At a share price of US$109.98, Entegris has seen short term momentum fade with a 1 month share price return decline of 17.58%. However, its year to date share price return of 22.8% and 1 year total shareholder return of 17% keep the longer term picture more constructive. This suggests that recent weakness may reflect shifting expectations around growth and risk rather than a clear change in the broader story.

If this semiconductor pullback has you looking wider across the chip ecosystem, our screener of 35 AI infrastructure stocks is a handy way to spot other names leveraged to similar long term technology trends.

With Entegris sitting at US$109.98 after a recent 17.58% 1 month pullback but solid returns over 3 years, the real question is whether you are looking at an undervalued compounder or a stock already pricing in future growth?

Most Popular Narrative: 22.9% Undervalued

With Entegris last closing at US$109.98 against a narrative fair value of about US$142.73, the current setup leans toward a discount that hinges on how its growth story plays out over time.

Investments and leadership in advanced materials for next-generation nodes, including CMP slurries, selective etch, and deposition materials, position Entegris to capitalize on upcoming node transitions (e.g., advanced logic, 3D NAND, HBM) and increasing semiconductor complexity, supporting higher ASPs and improved gross margins.

Read the complete narrative.

Curious what kind of revenue path and margin lift need to line up for that valuation to make sense? The narrative leans on ambitious earnings compounding and a rich future earnings multiple tied to Entegris’ role in next generation chip materials. Want to see how those assumptions stack together and where the discount rate really bites into today’s price?

Result: Fair Value of US$142.73 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are still real swing factors here, including exposure to cyclical chip demand and roughly US$4b of gross debt that could limit flexibility if conditions worsen.

Find out about the key risks to this Entegris narrative.

Another View: High P/E Puts Pressure On Execution

That 22.9% discount to narrative fair value sits alongside a very different signal from simple earnings multiples. At a P/E of 70.9x versus a fair ratio of 42.3x, the US Semiconductor average of 42.8x and a peer average of 40x, Entegris looks expensive on current earnings. The question is whether future profit growth can do enough heavy lifting to close that gap.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Does this mixed picture leave you unsure which signal to trust? Take a closer look at the full set of data now, including 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If this Entegris snapshot has sharpened your thinking, do not stop here. Use the tools at your fingertips to line up your next few ideas with intent.

• Target resilience first by checking companies in our 68 resilient stocks with low risk scores, a practical way to focus on businesses with fewer red flags on key risk metrics.
• Hunt for value by scanning the screener containing 25 high quality undiscovered gems, where you can spot quality names that are not yet crowded with attention.
• Prioritise financial strength through the solid balance sheet and fundamentals stocks screener (41 results), so you are focusing on companies with balance sheets that can support their plans.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com